Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS-Mediated Signalling Pathways

  • Wu, Wei (Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University) ;
  • Xia, Qing (Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University) ;
  • Luo, Rui-Jie (Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University) ;
  • Lin, Zi-Qi (Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University) ;
  • Xue, Ping (Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University)
  • Published : 2015.06.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: To investigate in-vitro antagonistic effect of low-dose liquiritigenin on gemcitabine-induced capillary leak syndrome (CLS) in pancreatic adenocarcinoma via inhibiting reactive oxygen species (ROS)-mediated signalling pathways. Materials and Methods: Human pancreatic adenocarcinoma Panc-1 cells and human umbilical vein endothelial cells (HUVECs) were pre-treated using low-dose liquiritigenin for 24 h, then added into gemcitabine and incubated for 48 h. Cell viability, apoptosis rate and ROS levels of Panc-1 cells and HUVECs were respectively detected through methylthiazolyldiphenyl-tetrazoliumbromide (MTT) and flow cytometry. For HUVECs, transendothelial electrical resistance (TEER) and transcellular and paracellular leak were measured using transwell assays, then poly (ADP-ribose) polymerase 1 (PARP-1) and metal matrix proteinase-9 (MMP9) activity were assayed via kits, mRNA expressions of p53 and Rac-1 were determined through quantitative polymerase chain reaction (qPCR); The expressions of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and PARP-1 were measured via western blotting. Results: Low-dose liquiritigenin exerted no effect on gemcitabine-induced changes of cell viability, apoptosis rate and ROS levels in Panc-1 cells, but for HUVECs, liquiritigenin ($3{\mu}M$) could remarkably elevate gemcitabine-induced decrease of cell viability, transepithelial electrical resistance (TEER), pro-MMP9 level and expression of ICAM-1 and VCAM-1 (p<0.01). Meanwhile, it could also significantly decrease gemcitabine-induced increase of transcellular and paracellular leak, ROS level, PARP-1 activity, Act-MMP9 level, mRNA expressions of p53 and Rac-1, expression of PARP-1 and apoptosis rate (p<0.01). Conclusions: Low-dose liquiritigenin exerts an antagonistic effect on gemcitabine-induced leak across HUVECs via inhibiting ROS-mediated signalling pathways, but without affecting gemcitabine-induced Panc-1 cell apoptosis. Therefore, low-dose liquiritigenin might be beneficial to prevent the occurrence of gemcitabine-induced CLS in pancreatic adenocarcinoma.

Keywords

References

  1. Axelsson J, Rippe A, Sverrisson K, et al (2013). Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. Am J Physiol Renal Physiol, 5, 237-43.
  2. Armstrong SM, Khajoee V, Wang C, et al (2012). Co-regulation of transcellular and paracellular leak across microvascular endothelium by dynamin and Rac. Am J Pathol, 180, 1308-23. https://doi.org/10.1016/j.ajpath.2011.12.002
  3. Biswas S, Nik S, Corrie PG (2004). Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease. Clin Oncol (R Coll Radiol), 16, 577-9. https://doi.org/10.1016/j.clon.2004.06.019
  4. Chen SH, Li DL, Yang F, et al (2014). Gemcitabine-induced pancreatic cancer cell death is associated with MST1/cyclophilin D mitochondrial complexation. Biochimie, 103, 71-9. https://doi.org/10.1016/j.biochi.2014.04.004
  5. Choi EM, Suh KS, Lee YS (2014). Liquiritigenin restores osteoblast damage through regulating oxidative stress and mitochondrial dysfunction. Phytother Res, 28, 880-6. https://doi.org/10.1002/ptr.5071
  6. Cheng ZX, Wang DW, Liu T, et al (2014). Effects of the HIF-1${\alpha}$ and NF-${\kappa}B$ loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells. Oncol Rep, 31, 1891-8. https://doi.org/10.3892/or.2014.3022
  7. Casadei Gardini A, Aquilina M, Oboldi D, et al (2013). Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease. BMC Cancer, 13, 542. https://doi.org/10.1186/1471-2407-13-542
  8. Dasanu CA (2008). Gemcitabine: vascular toxicity and prothrombotic potential. Expert Opin Drug Saf, 7, 703-16. https://doi.org/10.1517/14740330802374262
  9. Dahan L, Ressiot E, Cournede A, et al (2007). Anasarca, a complication of chemotherapy with gemcitabine in two patients with pancreatic cancer. Gastroenterol Clin Biol, 31, 1143-5. https://doi.org/10.1016/S0399-8320(07)78353-7
  10. De Pas T, Curigliano G, Franceschelli L, et al (2001). Gemcitabine-induced systemic capillary leak syndrome. Ann Oncol, 12, 1651-2. https://doi.org/10.1023/A:1013163831194
  11. Gaur R, Yadav KS, Verma RK, et al (2014). In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. Phytomedicine, 21, 415-22. https://doi.org/10.1016/j.phymed.2013.10.015
  12. Ju HQ, Gocho T, Aguilar M, et al (2014). Mechanisms of overcoming intrinsic resistance to gemcitabine in pancreatic ductal adenocarcinoma through the redox modulation. Mol Cancer Ther, [Epub ahead of print].
  13. Liu DL, Bu HQ, Jin HM, et al (2014). Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway. Mol Med Rep, 10, 3027-34. https://doi.org/10.3892/mmr.2014.2584
  14. Liu Z, Li D, Zheng X, et al (2013). Selective induction of apoptosis: promising therapy in pancreatic cancer. Curr Pharm Des, 9, 2259-68.
  15. Lau PC, Zheng SF, Ng WT, et al (2012). Inoperable pancreatic adenocarcinoma rendered complete remission by highintensity focused ultrasound concurrent with gemcitabinecapecitabine chemotherapy: case report and topic review. J Dig Dis, 13, 60-4. https://doi.org/10.1111/j.1751-2980.2011.00546.x
  16. Montero J, Dutta C, van Bodegom D, et al (2013). p53 regulates a non-apoptotic death induced by ROS. Cell Death Differ, 20, 1465-74. https://doi.org/10.1038/cdd.2013.52
  17. Matsuda A (1997). Nucleoside kinases and new types of antitumor nucleosides. Gan To Kagaku Ryoho, 24, 1594-9.
  18. Peng F, Du Q, Peng C, et al (2015). A review: the pharmacology of isoliquiritigenin. Phytother Res, [Epub ahead of print].
  19. Park SM, Ki SH, Han NR, et al (2015). Tacrine, an oral acetylcholinesterase inhibitor, induced hepatic oxidative damage, which was blocked by liquiritigenin through GSK3-beta inhibition. Biol Pharm Bull, 38, 184-92. https://doi.org/10.1248/bpb.b14-00430
  20. Pulkkanen K, Kataja V, Johansson R (2003). Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report. J Chemother, 15, 287-9. https://doi.org/10.1179/joc.2003.15.3.287
  21. Pan X, Kong LD, Zhang Y, et al (2000). In-vitro inhibition of rat monoamine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Acta Pharmacol Sin, 21, 949-53.
  22. Suzuki S, Okada M, Shibuya K, et al (2015). JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. Oncotarget, 6, 458-70. https://doi.org/10.18632/oncotarget.2693
  23. Srinivasan B, Kolli AR, Esch MB, et al (2015). TEER measurement techniques for in vitro barrier model systems. J Lab Autom, 20, 107-26. https://doi.org/10.1177/2211068214561025
  24. Singh M, Kaur M, Silakari O (2014). Flavones: an important scaffold for medicinal chemistry. Eur J Med Chem, 84, 206-39. https://doi.org/10.1016/j.ejmech.2014.07.013
  25. Suh KS, Rhee SY, Kim YS, et al (2014). Protective effect of liquiritigenin against methylglyoxal cytotoxicity in osteoblastic MC3T3-E1 cells. Food Funct, 5, 1432-40. https://doi.org/10.1039/c4fo00127c
  26. Stein DM, Scalea TM, (2012). Capillary leak syndrome in trauma: what is it and what are the consequences? Adv Surg, 46, 237-53. https://doi.org/10.1016/j.yasu.2012.03.008
  27. Taylor SC, Posch A (2014). The design of a quantitative western blot experiment. Biomed Res Int, 2014, 361590.
  28. Vacas E, Bajo AM, Schally AV, et al (2013). Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinoma. Mol Cell Endocrinol, 365, 212-22. https://doi.org/10.1016/j.mce.2012.10.021
  29. Wang R, Cheng L, Xia J, et al (2014). Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1${\alpha}$ in pancreatic cancer cells. Curr Cancer Drug Targets, 14, 407-17. https://doi.org/10.2174/1568009614666140226114015
  30. Wu X, Deng G, Li M, et al (2013). Wnt/${\beta}$-Catenin signaling reduces Bacillus Calmette-Guerin-induced macrophage necrosis through a ROS-mediated PARP/AIF-dependent pathway. BMC Immunol, 16, 16.
  31. Wong BS, Yoong SL, Jagusiak A, et al (2013). Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev, 65, 1964-2015. https://doi.org/10.1016/j.addr.2013.08.005
  32. Xie X, Zhang HD, Chen YZ, et al (2012). Chemical constituents and activities of total flavonoids from Yushen Tang. Chinese Materia Medica, 37, 3585-90.
  33. Yang EJ, Park GH, Song KS (2013). Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells. Neurotoxicology, 39, 114-23. https://doi.org/10.1016/j.neuro.2013.08.012
  34. Zhan YH, Huang XF, Hu XB, et al (2013). Growth inhibition and apoptosis induction of human umbilical vein endothelial cells by apogossypolone. Asian Pac J Cancer Prev, 14, 1791-5. https://doi.org/10.7314/APJCP.2013.14.3.1791

Cited by

  1. Protective effects of aloperine on neonatal rat primary cultured hippocampal neurons injured by oxygen–glucose deprivation and reperfusion vol.69, pp.4, 2015, https://doi.org/10.1007/s11418-015-0928-2
  2. Neuroprotective effects of syringic acid against OGD/R-induced injury in cultured hippocampal neuronal cells vol.38, pp.2, 2016, https://doi.org/10.3892/ijmm.2016.2623
  3. Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathway vol.5, pp.11, 2016, https://doi.org/10.1002/cam4.916
  4. Neuroprotective effects of orientin on oxygen-glucose deprivation/reperfusion-induced cell injury in primary culture of rat cortical neurons pp.1535-3699, 2018, https://doi.org/10.1177/1535370217737983